Peptide Synthesis Market by Product (Reagent, Synthesizer, Chromatography), Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), End User (Pharmaceuticals & Biotechnology, CRO), and Region - Global Forecast to 2023

The peptide synthesis market was valued at USD 292.4 million in 2017 and is projected to reach USD 426.4 million by 2023, at a CAGR of 6.5% during the forecast period. Market growth can be attributed to increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced peptide synthesizers.

Years considered for this report

• 2017 – Base Year
• 2018 – Estimated Year
• 2023 – Projected Year

Objectives of the Study

• To define, describe, and forecast the peptide synthesis market on the basis of product, technology, end user, and region
• To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
• To profile key players and comprehensively analyze their market shares and core competencies in the global peptide synthesis market
• To track and analyze competitive developments such as partnerships, agreements, & collaborations; mergers & acquisitions; product developments; and geographical expansions in the global peptide synthesis market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global peptide synthesis market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary sources secondary sources; directories; databases such as Hoovers, Bloomberg Businessweek, Factiva, and OneSource, journals and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data is consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

To know about the assumptions considered for the study, download the pdf brochure

The global peptide synthesis market is fragmented in nature. GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Switzerland), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden), Advanced ChemTech (US), New England Peptide, Inc (US) and Merck KGaA (Germany) are some of the major players operating in the peptide synthesis reagents market.

Target Audience:

• Biotechnology & pharmaceutical companies
• Market research and consulting firms
• Venture capitalists and investors
• Research & development companies
• Contract research organizations (CROs)
• Academic research institutes
• Government institutes

Scope of the Report

The research report categorizes the global peptide synthesis market into the following segments and subsegments:

Global Peptide Synthesis Market:

• By Products
  • Reagents
  • Equipment
    • Peptide Synthesizers
    • Chromatography equipment
    • Lyophilizers
• By Technology
  • Solid-phase Peptide Synthesis
  • Liquid-phase Peptide Synthesis
  • Hybrid & Recombinant Technology
• By End User
  • Pharmaceutical and Biotechnology Companies 
  • Contract Development and Manufacturing Organizations
  • Academic and Research Institutes
• By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

• Product matrix, which gives a detailed comparison of the product portfolios of key players

Geographic Analysis

• Further breakdown of the Rest of Asia Pacific peptide synthesis market into South Korea, Australia, New Zealand, and others
• Further breakdown of the Rest of Europe (RoE) peptide synthesis market into Belgium, Russia, the Netherlands, Switzerland, and others
• Further breakdown of the Rest of Latin America(RoLATAM) peptide synthesis market into Argentina, Colombia, Chile, and others

Company Information

• Detailed analysis and profiling of additional market players

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Sources
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Sources
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)
    4.1 Peptide Synthesis: Market Overview
    4.2 Europe: Peptide Synthesis Market, By Technology & End User (2017)
    4.3 Peptide Synthesis Market: Geographic Snapshot
    4.4 Peptide Synthesis: Geographic Mix

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Use of Peptides in Pharmaceutical Drugs
                    5.2.1.2 Increase in Research Activities and Availability of Funding for R&D
                    5.2.1.3 Development of Advanced Peptide Synthesizers
           5.2.2 Restraint
                    5.2.2.1 Lack of A Unified Set of Regulations for Therapeutic Peptides
           5.2.3 Opportunitie
                    5.2.3.1 Emerging Markets in the Asia Pacific Region
           5.2.4 Challenge
                    5.2.4.1 Issues Associated With the Route of Administration of Peptide Drugs

6 Peptide Synthesis Market, By Product (Page No. - 40)
    6.1 Introduction
    6.2 Reagents
    6.3 Equipment
           6.3.1 Peptide Synthesizers
           6.3.2 Chromatography Equipment
           6.3.3 Lyophilizers

7 Peptide Synthesis Market, By Technology (Page No. - 49)
    7.1 Introduction
    7.2 Solid-Phase Peptide Synthesis (SPPS)
    7.3 Solution-Phase Synthesis (SPS)
    7.4 Hybrid and Recombinant Technology

8 Peptide Synthesis Market, By End User (Page No. - 55)
    8.1 Introduction
    8.2 Pharmaceutical and Biotechnology Companies
    8.3 Contract Development and Manufacturing Organization/ Contract Research Organization
    8.4 Academic and Research Institutes

9 Peptide Synthesis Market, By Region (Page No. - 61)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 UK
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe
    9.4 Asia Pacific
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia Pacific
    9.5 Latin America
    9.6 Middle East and Africa

10 Competitive Landscape (Page No. - 102)
     10.1 Overview
     10.2 Competitive Scenario
     10.3 Growth Strategy Matrix
             10.3.1 Acquisitions
             10.3.2 Product Launches
             10.3.3 Agreements, Partnerships, and Collaborations
             10.3.4 Expansions

11 Company Profiles (Page No. - 106)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 Genscript Biotech
     11.2 Merck KGaA
     11.3 Aapptec
     11.4 Bachem Holdings
     11.5 Anaspec (A Subsidiary of Kaneka Eurogentec S.A.)
     11.6 Biotage
     11.7 CEM Corporation
     11.8 Gyros Protein Technologies
     11.9 Advanced Chemtech
     11.10 NEP (New England Peptide)

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 128)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details

List of Tables (92 Tables)

Table 1 Peptide Synthesis Market: Impact Analysis of Drivers, Restraints, Opportunities, and Challenges
Table 2 Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 3 Peptide Synthesis Reagents Market, By Country, 2016–2023 (USD Million)
Table 4 Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 5 Peptide Synthesis Equipment Market, By Country, 2016–2023 (USD Million)
Table 6 Major Peptide Synthesizers Available in the Market
Table 7 Peptide Synthesizers Market, By Country, 2016–2023 (USD Million)
Table 8 Peptide Synthesis Market for Chromatography Equipment, By Country, 2016–2023 (USD Million)
Table 9 Peptide Synthesis Market for Lyophilizers, By Country, 2016–2023 (USD Million)
Table 10 Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 11 Solid-Phase Peptide Synthesis Market, By Country 2016–2023 (USD Million)
Table 12 Solution-Phase Synthesis Market, By Country 2016–2023 (USD Million)
Table 13 Hybrid and Recombinant Peptide Synthesis Market, By Country, 2016–2023 (USD Million)
Table 14 Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 15 Peptide Synthesis Market for Pharmaceutical and Biotechnology Companies, By Country, 2016–2023 (USD Million)
Table 16 Peptide Synthesis Market for Contract Development and Manufacturing Organizations, By Country, 2016–2023 (USD Million)
Table 17 Peptide Synthesis Market for Academic and Research Institutes, By Country, 2016–2023 (USD Million)
Table 18 North America: Peptide Synthesis Market, By Country, 2016–2023 (USD Million)
Table 19 North America: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 20 North America: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 21 North America: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 22 North America: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 23 US: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 24 US: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 25 US: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 26 US: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 27 Canada: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 28 Canada: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 29 Canada: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 30 Canada: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 31 Europe: Peptide Synthesis Market, By Country, 2016–2023 (USD Million)
Table 32 Europe: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 33 Europe: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 34 Europe: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 35 Europe: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 36 Germany: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 37 Germany: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 38 Germany: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 39 Germany: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 40 UK: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 41 UK: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 42 UK: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 43 UK: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 44 France: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 45 France: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 46 France: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 47 France: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 48 Italy: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 49 Italy: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 50 Italy: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 51 Italy: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 52 Spain: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 53 Spain: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 54 Spain: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 55 Spain: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 56 RoE: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 57 RoE: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 58 RoE: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 59 RoE: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 60 Asia Pacific: Peptide Synthesis Market, By Country, 2016–2023 (USD Million)
Table 61 Asia Pacific: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 62 Asia Pacific: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 63 Asia Pacific: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 64 Asia Pacific: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 65 China: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 66 China: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 67 China: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 68 China: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 69 Japan: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 70 Japan: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 71 Japan: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 72 Japan: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 73 India: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 74 India: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 75 India: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 76 India: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 77 RoAPAC: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 78 RoAPAC: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 79 RoAPAC: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 80 RoAPAC: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 81 Latin America: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 82 Latin America: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 83 Latin America: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 84 Latin America: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 85 Middle East & Africa: Peptide Synthesis Market, By Product, 2016–2023 (USD Million)
Table 86 Middle East & Africa: Peptide Synthesis Equipment Market, By Type, 2016–2023 (USD Million)
Table 87 Middle East & Africa: Peptide Synthesis Market, By Technology, 2016–2023 (USD Million)
Table 88 Middle East & Africa: Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Table 89 Key Acquisitions, January 2015 – June 2018
Table 90 Key Product Launches, January 2015– June 2018
Table 91 Key Agreements, Partnerships, and Collaborations, January 2015 – June 2018
Table 92 Key Expansions, January 2015 – June 2018

List of Figures (29 Figures)

Figure 1 Research Design
Figure 2 Primary Sources
Figure 3 Breakdown of Primary Interviews(Supply Side): By Company Type, Designation, and Region
Figure 4 Breakdown of Primary Interviews(Demand Side): By End User, Designation, and Region
Figure 5 Bottom-Up Approach
Figure 6 Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Peptide Synthesis Market, By Product, 2018 vs 2023 (USD Million)
Figure 9 Peptide Synthesis Market, By Technology, 2018 vs 2023 (USD Million)
Figure 10 Peptide Synthesis Market, By End User, 2018 vs 2023 (USD Million)
Figure 11 Geographical Snapshot of the Peptide Synthesis Market
Figure 12 Increasing Use of Peptides in the Pharmaceutical Industry is Driving Market Growth
Figure 13 The Pharmaceutical and Biotechnology Companies Segment Commanded the Largest Share of the Peptide Synthesis Market in 2017
Figure 14 The US Accounted for the Largest Share of the Peptide Synthesis Market in 2017
Figure 15 APAC to Register the Highest CAGR During the Forecast Period
Figure 16 Reagents Segment to Dominate the Peptide Synthesis Market During the Forecast Period
Figure 17 Solid-Phase Peptide Synthesis to Dominate the Peptide Synthesis Technology Market During the Forecast Period
Figure 18 Peptide Synthesis Market, By End User, 2016–2023 (USD Million)
Figure 19 Peptide Synthesis Market: Geographic Growth Opportunities
Figure 20 Peptide Synthesis Market, By Region, 2016–2023 (USD Million)
Figure 21 North America: Peptide Synthesis Market Snapshot
Figure 22 Europe: Peptide Synthesis Market Snapshot
Figure 23 Asia Pacific: Peptide Synthesis Market Snapshot
Figure 24 Key Developments in the Peptide Synthesis Market Between January 2015 and June 2018
Figure 25 Genscript: Company Snapshot (2017)
Figure 26 Merck KGaA: Company Snapshot (2017)
Figure 27 Bachem Holdings: Company Snapshot (2017)
Figure 28 Kaneka Corporation: Company Snapshot (2017)
Figure 29 Biotage: Company Snapshot (2017)

The peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5% during the forecast period. Factors such as the growing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced peptide synthesizers are expected to drive the growth of the market. However, the lack of a unified set of regulations for therapeutic peptides is expected to restrain the growth of this market during the forecast period.

In this report, the peptide synthesis market has been segmented by product, technology, and end user. This report also provides market information based on key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Based on product, peptide synthesis market has been segmented into reagents and equipment. The equipment segment has been subsegmented into peptide synthesizers, chromatography equipment, and lyophilizers. This segment is expected to grow at the highest CAGR in the next five years. Technological innovations, automation, and advancements in instruments; replacement of older equipment with new ones; increasing demand from the Asian market; and growing demand for synthesized peptides, are factors driving the high growth of this market.

By technology, the peptide synthesis market has been segmented into solid-phase synthesis, liquid-phase synthesis, and hybrid & recombinant technology. Solid-phase synthesis held the largest share of the peptide synthesis market in 2017 due to advantages such as ease of operation, easy purification, short production cycles, high-level automation, and synthesis capabilities of long peptides in small quantities of amino acids.

By end user, the global peptide synthesis market is segmented into pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic and research institutes. The contract development and manufacturing organizations segment is projected to grow at the highest CAGR in the peptide synthesis market. Increasing demand for cost-effective peptide synthesis services in drug development activities and life science research is a key driver for this end-user segment.

North America dominated the peptide synthesis market, followed by Europe during the forecast period. In North America, the US is expected to hold the largest share of the peptide synthesis market due to increasing research activity and the growing prevalence of cancer and chronic diseases.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period and countries such as Japan, China, and India are expected to provide significant growth opportunities for market players.

The prominent players in the peptide synthesis market are GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Switzerland), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden), Advanced ChemTech (US), Merck KGAA (Germany) and New England Peptide (US). Product launches and agreements, partnerships and collaborations were the major strategies adopted by these payers to maintain their positions in the peptide synthesis market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst